5-Aminolevulinic acid and its derivatives:: physical chemical properties and protoporphyrin IX formation in cultured cells

被引:190
作者
Uehlinger, P
Zellweger, M
Wagnières, G
Juillerat-Jeanneret, L
van den Bergh, H
Lange, N [1 ]
机构
[1] Swiss Fed Inst Technol, EPFL, Inst Environm Engn, CH-1015 Lausanne, Switzerland
[2] CHUV Hosp, Inst Pathol, CH-1011 Lausanne, Switzerland
关键词
5-aminolevulinic acid; 5-aminolevulinic acid esters; photodynamic therapy (PDT); fluorescence; protoporphyrin IX; ALA esters; lipophilicity;
D O I
10.1016/S1011-1344(99)00159-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protoporphyrin IX (PpIX) is used as a fluorescence marker and photosensitizing agent in photodynamic therapy (PDT). A temporary increase of PpIX in tissues can be obtained by administration of 5-aminolevulinic acid (ALA). Lipophilicity is one of the key parameters defining the bioavailability of a topically applied drug. In the present work, octanol-water partition coefficients of ALA and several of its esters have been determined to obtain a parameter related to their lipophilicity. The influence of parameters such as lipophilicity, concentration, time, and pH value on PpIX formation induced by ALA and its esters is then investigated in human cell lines originating from the lung and bladder. ALA esters are found to be more lipophilic than the free acid. The optimal concentration (c(opt), precursor concentration at which maximal PpIX accumulation is observed) is then measured for each precursor. Long-chained ALA esters are found to decrease the c(opt) value by up to two orders of magnitude as compared to ALA. The reduction of PpIX formation observed at higher concentrations than c(opt) is correlated to reduced cell viability as determined by measuring the mitochondrial activity. Under optimal conditions, the PpIX formation rate induced by the longer-chained esters is higher than that of ALA or the shorter-chained esters. A biphasic pH dependence on PpIX generation is observed for ALA and its derivatives. Maximal PpIX formation is measured under physiological conditions (pH 7.0-7.6), indicating that further enhancement of intracellular PpIX content may be achieved by adjusting the pharmaceutical formulation of ALA or its derivatives to these pH levels. (C)2000 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 42 条
  • [21] HEME-BIOSYNTHETIC ENZYME-ACTIVITIES AND PORPHYRIN ACCUMULATION IN NORMAL LIVER AND HEPATOMA-CELL LINES OF RAT
    KONDO, M
    HIROTA, N
    TAKAOKA, T
    KAJIWARA, M
    [J]. CELL BIOLOGY AND TOXICOLOGY, 1993, 9 (01) : 95 - 105
  • [22] In-vitro investigation of ALA-induced protoporphyrin IX
    Krammer, B
    Uberriegler, K
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1996, 36 (02) : 121 - 126
  • [23] Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer
    Kriegmair, M
    Baumgartner, R
    Lumper, W
    Waidelich, R
    Hofstetter, A
    [J]. BRITISH JOURNAL OF UROLOGY, 1996, 77 (05): : 667 - 671
  • [24] FLUORESCENCE PHOTODETECTION OF NEOPLASTIC UROTHELIAL LESIONS FOLLOWING INTRAVESICAL INSTILLATION OF 5-AMINOLEVULINIC ACID
    KRIEGMAIR, M
    EHSAN, A
    BAUMGARTNER, R
    LUMPER, W
    KNUECHEL, R
    HOFSTADTER, F
    STEINBACH, P
    HOFSTETTER, A
    [J]. UROLOGY, 1994, 44 (06) : 836 - 841
  • [25] Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
    Kriegmair, M
    Baumgartner, R
    Knuchel, R
    Stepp, H
    Hofstadter, F
    Hostetter, A
    [J]. JOURNAL OF UROLOGY, 1996, 155 (01) : 105 - 109
  • [26] Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX:: a pilot study
    Lange, N
    Jichlinski, P
    Zellweger, M
    Forrer, M
    Marti, A
    Guillou, L
    Kucera, P
    Wagnières, G
    van den Bergh, H
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 185 - 193
  • [27] Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: An in vitro approach
    Marti, A
    Lange, N
    Van den Bergh, H
    Sedmera, D
    Jichlinski, P
    Kucera, P
    [J]. JOURNAL OF UROLOGY, 1999, 162 (02) : 546 - 552
  • [28] MARTIN A, 1995, ARCH DERMATOL RES, V287, P665
  • [29] Moan J, 1997, INT J CANCER, V70, P90, DOI 10.1002/(SICI)1097-0215(19970106)70:1<90::AID-IJC14>3.0.CO
  • [30] 2-H